Geron Corp (GERN) option IV into FDA Oncologic Drugs Advisory Committee meeting

Go back to Geron Corp (GERN) option IV into FDA Oncologic Drugs Advisory Committee meeting
Geron Corp (NASDAQ: GERN) Delayed: 1.39 --0 (-0%)
Previous Close $1.39    52 Week High $5.30 
Open $1.39    52 Week Low $1.81 
Day High $1.39    P/E N/A 
Day Low $1.39    EPS $-0.35 
Volume 10,423